Education | Research Sponsor Interest | General Research Interest | Selected Research Projects
Research and Clinical Interests | Selected Publications

Lluis Ferrer, DVM, DECVD, PhD
Professor of Veterinary Dermatology
Department of Clinical Sciences
Phone: 508-887-4419
Fax: 508-839-7922
Email: lluis.ferrer@tufts.edu

Education

Licenciado en Veterinaria (DVM), Universidad de Zaragoza, Spain - 1981
Master in Animal Pathology, Veterinary School of Hannover, Germany - 1983
PhD in Veterinary Science, Universidad de Zaragoza, Spain - 1985

Board Certification

Diplomate, European College of Veterinary Dermatology - 1995

General Research Interests

  • Canine demodicosis
  • Canine leishmaniosis
  • Hyaluronosis in Chinese Shar Peis and other genodermatosis
  • Innate immunity in the skin

Selected Research Projects

  • "Deconstructing demodicosis", sponsored by the ECVD-ESVD
  • "Copy number variation as a disease cause in shar pei mucinosis", Spanish Ministry of Science and Technology

Teaching

  • Clinical Dermatology
Back to the Top

Selected Publications

  1. Ravera I, Altet L, Francino O, Sanchez A, Roldan W, Villanueva S, Bardagi M, Ferrer L. Small Demodex populations colonize most parts of the skin of healthy dogs. Veterinary Dermatology Feb 24 (1): 168-72.e37. doi: 10.1111/j.1365-3164.2012.01099.x (2013).
  2. Sastre N, Ravera I, Villanueva S, Altet L, Bardagí M, Sánchez A, Francino O, Ferrer L. Phylogenetic relationships in three species of canine Demodex mite based on partial sequences of mitochondrial 16S rDNA. Veterinary  Dermatology Dec 23(6):509-e101. doi: 10.1111/vde.12001. (2012).
  3. Quílez J, Martínez V, Woolliams J, Sánchez A, Pong-Wong R, Kennedy L, Quinnell R, Ollier W, Roura X, Ferrer L, Altet L, Francino O. Genetic control of canine leishmaniosis: genome-wide association study and genomic selection analysis. PLoSOne, Epublication (2012).
  4. Bardagí M, Fondevila D, Ferrer L. Cyclooxigenase-2 is not expressed by canine cutaneous epitheliotropic lymphoma. Veterinary Dermatology doi: 10.1111/j.1365-3164.2012.01066.x (2012).
  5. Mueller R, Bensignor E, Ferrer L, Holm B, Lemarie S, Paradis M, Shipstone MA. Treatment of demodicosis in dogs: 2011 clinical practice guidelines. Veterinary Dermatology 23, 86-96 (2012).
  6. Zanna G, Fondevila D, Ferrer L, Espada Y. Evaluation of ultrasonography for measurement of skin thickness in Shar-Peis. American Journal of Veterinary Research 73, 220-6 (2012).
  7. Docampo MJ, Zanna G, Fondevila D, Cabrera J, López-Iglesias C, Carvalho A, Cerrato S, Ferrer , Bassols A. Increased HAS2-driven hyaluronic acid synthesis in shar-pei dogs with hereditary cutaneous hyaluronosis (mucinosis). Veterinary Dermatology 22, 535-45 (2011).
  8. Bardagi M, Fondevila D, Ferrer L. Immunohistochemical Detection of COX-2 in Feline and Canine Actinic Keratoses and Cutaneous Squamous Cell Carcinoma. Article in press. Journal of Comparative Pathology 146, 11-7 (2011).
  9. Solano-Gallego L, Miró G, Koutinas A, Cardoso L, Pennisi M, Ferrer L, Bourdeau P, Oliva G, Baneth G. LeishVet guidelines for the practical management of canine leishmaniosis. Parasites and Vectors 4, 1-16 (2011).
  10. Olsson M, Meadows J, Truvé K, Pielberg R, Puppo Mauceli E, Quilez J, Tonomura T, Zanna G, Docampo MJ, Bassols A, Avery A, Karlsson EK, Thomas A, Kastner D, Bongcam-Rudloff E, Webster MT, Sanchez A, Hedhammar A, Remmers E, Andersson L, Ferrer L, Tintle L, Lindblad-Toh K. A Novel Unstable Duplication Upstream of HAS2 Predisposes to a Breed-Defining Skin Phenotype and a Periodic Fever Syndrome in Chinese Shar-Pei Dogs. PLoS Genetics 7, p.1001332 (2011).
  11. Bardagi M, Montoliu P, Ferrer L, Fondevila D, Pumarola M. Acral Mutilation Syndrome in a Miniature Pinscher. Journal of Comparative Pathology 144: 235-8 (2011).
  12. Ravera I, Altet L, Francino O, Bardagí M, Sánchez A, Ferrer L. Development of a real-time PCR to detect Demodex canis DNA in different tissue samples. Parasitology Research 108: 305-8 (2011).
  13. Torres M, Bardagí M, Roura X, Zanna G, Ravera I, Ferrer L. Long-term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. The Veterinary Journal 188: 346-51 (2011).

Back to the Top